Log In
BCIQ
Print this Print this
 

PeproStat

  Manage Alerts
Collapse Summary General Information
Company Ergomed plc
DescriptionPeptide-based hemostat that binds fibrinogen
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBleeding
Indication DetailsControl bleeding during surgery
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$40.9M

$11.7M

$29.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/26/2016

$40.9M

$11.7M

$29.2M

Get a free BioCentury trial today